BECOTIDE 250 micrograms/dose, solution for inhalation in a pressurised container 200 doses
Active ingredients: BÉCLOMÉTASONE (DIPROPIONATE DE)
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation200 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BECOTIDE 250 microgrammes/dose, solution pour inhalation en flacon pressurisé
- Pharmaceutical form
- solution pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 flacon(s) pressurisé(s) aluminium avec valve(s) doseuse(s) avec embout(s) buccal(aux) de 200 dose(s)
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61749562CIP74900358CIP133400949003587Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉCLOMÉTASONE (DIPROPIONATE DE)solution | 250 microgrammes · une dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.